Navigation Links
Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
Date:2/26/2008

REINACH, Switzerland, February 26 /PRNewswire-FirstCall/ -- Arpida Ltd. (SWX: ARPN) today reported that the rolling submission of the New Drug Application (NDA) for intravenous iclaprim in its first indication, complicated Skin and Skin Structure Infections (cSSSI) will be completed within the next few weeks.

Arpida has agreed with the U.S. Food and Drug Administration (FDA) to file the NDA in a rolling process. Using a 'rolling NDA' allows modules within the overall package to be filed individually. Arpida has further agreed to file the NDA in an electronic format. Both the rolling NDA and the electronic format could potentially facilitate the review process.

Dr Khalid Islam, President and CEO of Arpida Ltd., commented: "Completing the submission of the NDA as soon as possible, while at the same time maintaining high standards of quality, remains our highest priority. Unfortunately, some of the data to be included in the NDA package were delivered later than anticipated. These delays were amplified by the additional processing steps that need to be taken for the electronic format in which we are filing, such as the incorporation of hyperlinks between the different parts of this huge and complex data package. We have only limited reference data regarding such projects and we underestimated the magnitude of the additional processing steps. Our development team and our external partners have been doing their utmost to complete the project within the February timeline. Rushing through the final processing procedure could jeopardise the quality. We strongly believe that safeguarding a high quality level at this crucial stage of iclaprim's development process is in the best interest of our stakeholders in the longer term. Based on the current status of the project, we anticipate the filing to be completed within the next few weeks."

Conference Call

Arpida will host a conference call to discuss this news release, 27

February
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arpida Interim Results for six Months to 30 June 2007
2. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
3. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
4. Arpida Presents Preclinical Data on AR-2474 at ICAAC
5. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
6. Arpida-Supported CME Symposium Available Online
7. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
8. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
9. CardioDynamics Provides 2007 Shareholder Meeting Update
10. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
11. NxStage Medical Provides Update on Medisystems Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... FierceBiotech today announced its annual “Fierce 15” ... 2014. FierceBiotech editors John Carroll and Damian Garde ... Those selected are identified as some of the ... , "It's always a lot of fun to ... said Carroll. "This year in particular you'll find quite ...
(Date:9/22/2014)... METTLER TOLEDO is pleased to ... device CNS110 ScanTape™ . Replacing a traditional ... greater ease and accuracy for transport and logistics ... enhance productivity—an important benefit for load planning and ... profits. , Usable at any point in ...
(Date:9/21/2014)... University of Basel in Switzerland have succeeded in ... molecule for the first time. These extremely weak ... molecular properties and may also contribute to the ... results were published in the scientific journal ... the interaction between matter and light, is probably ...
(Date:9/20/2014)... USA (PRWEB) September 20, 2014 Entries ... 2015 Prism Awards for Photonics Innovation . The ... the multi-billion dollar optics and photonics industry, and is ... and photonics , and Photonics Media . , ... the versatility of photonics, said SPIE CEO Eugene Arthurs. ...
Breaking Biology Technology:FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2ScanTape™ Handheld Dimensioner Increases Processing Volume 2Uncovering the forbidden side of molecules 2Entry deadline is 10 October for international photonics Prism Awards 2Entry deadline is 10 October for international photonics Prism Awards 3Entry deadline is 10 October for international photonics Prism Awards 4
... Powerful effects seen in all subjects including those ... of myocardial infarct patients, TSX Exchange Symbol: ... or the "Company") (TSX:RVX) announced today that results from the ... by successfully concluding the drug, RVX-208, is safe and tolerable. ...
... fills the world,s landfills into biofuel may be the ... tackling carbon emissions, claim scientists in Singapore and Switzerland. ... , reveals how replacing gasoline with biofuel from processed ... Biofuels produced from crops have proven controversial because they ...
... ARBOR, Mich.---University of Michigan physicists have created the ... step toward the goal of producing "designer dots" ... Quantum dots---often called artificial atoms or nanoparticles---are tiny ... photovoltaic cells, light-emitting devices and other technologies. Each ...
Cached Biology Technology:Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 2Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 3Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 4Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 5U-M physicists create first atomic-scale map of quantum dots 2
(Date:9/22/2014)... discovered a key molecular cog in a plant,s biological ... (daily) rhythms based on temperature. , Transcription factors, or ... external stresses such as light, rain, soil quality, ... researchers at USC has isolated one, called FBH1, that ... there as needed while in keeping it on a ...
(Date:9/22/2014)... in this image burn in Khabarovsk Krai, a territory occupying ... hotspots, accompanied by plumes of smoke mark active fires. The ... east towards the Sea of Okhotsk. Taiga and ... forest inhabit the central depression, and deciduous forests are the ... common in Russia in the summer, the 2014 wildfire season ...
(Date:9/22/2014)... and larger areas of sea ice melt in the summer ... it is thinner and more reduced. As the Arctic summers ... warming, because reduced sea ice in the Arctic will remove ... our results are representative, then sea ice plays a greater ... in future global CO2 budgets", says Dorte Haubjerg Sgaard, PhD ...
Breaking Biology News(10 mins):Genetic switch regulates a plant's internal clock based on temperature 2Arctic sea ice helps remove CO2 from the atmosphere 2
... a common non-motor symptom of Parkinson,s disease whose ... with psychosis has been shown to induce injury ... cortical areas. Jingmei Zhong and colleagues from First ... diffusion tensor imaging study in parkinson,s disease patients ...
... Penn Medicine researcher is among the winners of ... fast track his lab,s work to stop drug-resistant bacteria. ... with, and as a result more than 2 million people ... least 23,000 people die as a direct result. With ...
... source of phytochemicals called polyphenols, which have been reported by ... of protective health benefits. A new study by researchers at ... evidence. This new research, published today in ... that regular long-term wild blueberry diets may help improve or ...
Cached Biology News:Targeting evolution: Could this be the next strategy to stop superbugs? 2Health benefits of wild blueberries abound: Study 2
... DeStreak Reagent, 1 ml. ... 2-D gels by preventing streaking.Eliminates ... oxidation of proteins.Stabilizes proteins throughout ... simplified, well-resolved protein patterns.Ideal for ...
Request Info...
GENOMIPHI HY KIT 1000 RXN, 1 EA. Category: Genomics DNA Amplification....
LIVE/DEAD® Sperm Viability Kit *200-1000 assays*...
Biology Products: